Literature DB >> 6296113

De novo purine synthesis in human lymphocytes. Partial co-purification of the enzymes and some properties of the pathway.

E McCairns, D Fahey, D Sauer, P B Rowe.   

Abstract

A partially purified enzyme extract from lectin-transformed human peripheral blood lymphocytes synthesized purine nucleotides de novo. Although the relatively lower specific activity of the pathway compared with that in the avian liver preparation previously described (Rowe, P. B., McCairns, E., Madsen, G., Sauer, D., and Elliott, H. (1978) J. Biol. Chem. 253, 7711-7721) limited the extent of purification, a number of properties were established: (i) Ammonia could be utilized as readily as glutamine for the synthesis of phosphoribosylamine but only glutamine provided N-3 of the purine ring; (ii) in the presence of either GTP or NAD, AMP or GMP were synthesized; (iii) purine synthesis was inhibited at the level of phosphoribosylamine synthesis by both AMP and GMP, irrespective of whether ammonia or glutamine was the N donor; (iv) while the synthesis of AMP and GMP from IMP was self-regulated, GTP also appeared to be an inhibitor of the synthesis of GMP from IMP; (v) amidophosphoribosyltransferase was isolated from both transformed and nontransformed cells in a low molecular weight form which was converted to a high molecular weight form in the presence of GMP; and (vi) no evidence was obtained for the existence of a classical multienzyme complex for purine synthesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296113

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Molecular genetic analysis of Saccharomyces cerevisiae C1-tetrahydrofolate synthase mutants reveals a noncatalytic function of the ADE3 gene product and an additional folate-dependent enzyme.

Authors:  C K Barlowe; D R Appling
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Detection of inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase by thioinosinic acid and azathioprine by a new colorimetric assay.

Authors:  T Ha; S L Morgan; W H Vaughn; I Eto; J E Baggott
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Uptake of free adenosine and adenosine from adenosine monophosphate by human peripheral blood lymphocytes: possible kinetic role for ecto-5'-nucleotidase in the regulation of intracellular adenosine.

Authors:  T Shah; R J Simpson; A D Webster; T J Peters
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

Review 4.  Revisiting and revising the purinosome.

Authors:  Alice Zhao; Mark Tsechansky; Andrew D Ellington; Edward M Marcotte
Journal:  Mol Biosyst       Date:  2014-01-10

5.  De novo purine synthesis in cultured rat embryos undergoing organogenesis.

Authors:  P B Rowe; S E McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs.

Authors:  J E Baggott; S L Morgan; T Ha; W H Vaughn; R J Hine
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

7.  Changes in levels of actin and tubulin mRNAs upon the lectin activation of lymphocytes.

Authors:  E McCairns; D Fahey; G E Muscat; M Murray; P B Rowe
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

8.  Formycin B-resistant mutants of Chinese hamster ovary cells: novel genetic and biochemical phenotype affecting adenosine kinase.

Authors:  K D Mehta; R S Gupta
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

9.  Role of folate dependent transformylases in synthesis of purine in bone marrow of man and in bone marrow and liver of rats.

Authors:  R Deacon; I Chanarin; M Lumb; J Perry
Journal:  J Clin Pathol       Date:  1985-12       Impact factor: 3.411

10.  Multienzyme interactions of the de novo purine biosynthetic protein PAICS facilitate purinosome formation and metabolic channeling.

Authors:  Jingxuan He; Ling-Nan Zou; Vidhi Pareek; Stephen J Benkovic
Journal:  J Biol Chem       Date:  2022-03-21       Impact factor: 5.486

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.